WILLIAM OF OCKHAM AP EURO FULL
WILLIAM OF OCKHAM AP EURO TRIAL

Infertility decreased from 18.2% to 4.3%. In their systematic review of 13 studies involving 2,130 patients, the preoperative incidence of PCOS of 45.6% decreased to 6.8% after 12 months. The efficacy of metabolic surgery in the treatment of polycystic ovary syndrome (PCOS) led the European Society for Endocrinology to recommend that surgery be included as a treatment for PCOS. , based on a systematic review and meta-analysis of 32 cohort studies, found that metabolic surgery resulted in a biopsy-confirmed resolution of NASH in 66% of patients, inflammation in 50%, ballooning degeneration in 76%, and fibrosis in 40%. NASH, the most common cause of cirrhosis, is also improved. reported significant reduction in carotid intima-media thickness in 22 patients at 3 levels-bulb, common, and internal carotid-with a 1-, 3-, 6-, and 12-month follow-up. Metabolic surgery can also reduce the thickness of atherosclerotic plaques. for end-stage heart failure patients, bariatric surgery has been successfully used for weight loss as a bridge to cardiac transplantation.” Kindel and Strande, in their systematic review, concluded that surgery “significantly improves cardiac geometry, function, and symptoms related to obesity cardiomyopathy. , in a comparison of 287,438 adult patients with T2D versus 2,287 patients who underwent metabolic surgery, found a significantly lower risk of myocardial infarction, ischemic stroke, and mortality in the operated group. Metabolic surgery has also been shown to improve cardiac function and decrease cardiac adverse events. , the requirement for antidiabetic medications fell to zero in the surgical group while the level of medications remained the same in the medical cohort ( Fig. In a comparison of intensive medical therapy versus the RYGB by Schauer et al.

WILLIAM OF OCKHAM AP EURO FULL

Among the 488 subjects with T2D, the rates of full remission at 1, 3, 5, and 7 years were 71.2%, 69.4%, 64.6% and 60.2%, respectively. We were startled, in 1982, when glucose values returned to normal within a week after the RYGB, an observation confirmed in our LABS series. The operations also offer the most effective treatment for T2D. None regained their original weight ( Fig.

WILLIAM OF OCKHAM AP EURO TRIAL

In the Longitudinal Assessment of Bariatric Surgery (LABS) trial involving 1,738 patients with severe obesity who underwent the Roux-en-Y gastric bypass (RYGB), a mean loss of 28.4% of original weight was maintained for 7 years. Metabolic surgery, previously known as bariatric surgery, is the most effective treatment for severe obesity. Multiple clinical trials reflect the efficacy of surgery.

William of ockham ap euro